The Levothyroxine Sodium Tablets, cataloged under National Stock Number 6505-01-366-0962, is classified within Federal Supply Class 6505 (No Item Name Available) of the Medical, Dental, and Veterinary Equipment group. The primary manufacturer of record is Abbvie Inc. Government technical data includes 4 verified specifications, sourced from the Federal Logistics Information System (FLIS). This item has 11 commercial cross-references from 9 manufacturers, enabling identification through both NSN and commercial part number lookups. 12 verified substitutes exist in the FLIS interchangeability database. Current acquisition status: Active. Unit of issue: BT.
| Parameter | Value |
|---|---|
| NSN | 6505-01-366-0962 |
| Primary Part Number | NDC00074-5182-19 |
| Item Name | Levothyroxine Sodium Tablets |
| FSC / FSG | 6505 / 65 — No Item Name Available |
| Manufacturer | Abbvie Inc |
| Status | ACTIVE |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Content Quantity | 1000.000 TABLETS |
| Active Medicament Medicinal Strength | 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| HAZMAT | No |
| Unit of Issue | BT |
| Part Number | Manufacturer |
|---|---|
| NDC00074-5182-19 PRIMARY | Abbvie Inc (USA) |
| NDC00480-8690-10 | Teva Pharmaceuticals Usa, Inc. (USA) |
| NDC00048-1050-05 | Boots Pharmaceuticals Inc (USA) |
| F92I233 | Air Force Medical Logistics Office (USA) |
| SYNTHROID TABLETS | Boots Pharmaceuticals Inc (USA) |
| NDC72865-0238-10 | Xlcare Pharmaceuticals Inc (USA) |
| SYNTHROID | Boots Pharmaceuticals Inc (USA) |
| NDC60793-0852-10 PRIMARY | Pfizer Inc (USA) |
| NDC72162-1460-00 | Bryant Ranch Prepack Dba Bryant Ranch Prepack Inc (USA) |
| NDC69238-1832-07 | Amneal Pharmaceuticals of New York, Llc (USA) |
| NDC47781-0646-10 | Alvogen, Inc. (USA) |
NSN 6505-01-366-0962 is a Levothyroxine Sodium Tablets, manufactured by Abbvie Inc, classified under FSC 6505 (No Item Name Available). Status: active.
NSN 6505-01-366-0962 has 11 cross-referenced part numbers: NDC00074-5182-19 (Abbvie Inc), NDC00480-8690-10 (Teva Pharmaceuticals Usa, Inc.), NDC00048-1050-05 (Boots Pharmaceuticals Inc), F92I233 (Air Force Medical Logistics Office), SYNTHROID TABLETS (Boots Pharmaceuticals Inc) and 6 more.
There are 12 known substitutes for 6505-01-366-0962: 6505-00-915-1630, 6505-00-990-2021, 6505-01-042-9260 and 9 more. Verify interchangeability with system specifications before substitution.
Key specifications for NDC00074-5182-19: Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Content Quantity: 1000.000 TABLETS; Part Name Assigned by Controlling Agency: LEVOTHYROXINE SODIUM TABLETS USP 75MCG 1000S BT; Active Medicament Medicinal Strength: 75.000 MICROGRAMS LEVOTHYROXINE SODIUM ACTIVE INGREDIENT. 5 total characteristics are documented in the Federal Logistics Information System.